Calero Mdsl Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Calero Mdsl Limited - overview
Established
1961
Location
London, England, UK
Primary Industry
Consumer Products
About
Established in 1961 and headquartered in London, UK, Vemedia engages in the manufacture and sale of over the counter healthcare products and pharmaceutical ingredients. The company opearates a variety of brands including Excilor, a fungal nail treatment, Valdispert, central nervous system product, and Oenobiol, a beauty nutrition product.
Current Investors
Charterhouse Capital Partners, Cooperation Pharmaceutique Francaise
Primary Industry
Consumer Products
Sub Industries
Consumer Products, Pharmaceuticals
Website
www.vemedia.com
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Calero Mdsl Limited - timeline of key events
Calero Mdsl Limited - financials
| Fiscal Year Ended | Jan 01, 2011 | Jan 01, 2012 | Jan 01, 2013 | Jan 01, 2014 | Jan 01, 2015 | Jan 01, 2016 | Jan 01, 2017 | Jan 01, 2018 | Jan 01, 2019 | Jan 01, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 56,646,000.279 | - | - | - | - | - | - | - | - | - | 13,948,571 | 20,360,323 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | 11,329,200.056 | - | - | - | - | - | - | - | - | - | 1,347,197 | 3,455,665 | - | - | - |
| Operating Income (USD) | - | - | - | - | - | - | - | - | - | - | (1,946,485) | (896,363) | - | - | - |
| Operating Margin | - | - | - | - | - | - | - | - | - | - | (14.0%) | (4.4%) | - | - | - |
| % EBITDA Margin | 20.0% | - | - | - | - | - | - | - | - | - | 9.7% | 17.0% | - | - | - |
| NET Income (USD) | 4,205,536.384 | - | - | - | - | - | - | - | - | - | (129,703) | (1,660,515) | - | - | - |
| % Net Margin | 7.4% | - | - | - | - | - | - | - | - | - | (0.9%) | (8.2%) | - | - | - |
Calero Mdsl Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on, Trade Sale | Completed | Calero Mdsl Limited | - | ||||||||
| Add-on | Completed | Stardea | - | ||||||||
| Add-on | Completed | Oenobiol | - | ||||||||
| Add-on | Completed | Labima SA | - | ||||||||
| Public to Private, Secondary Buyout | Completed | Calero Mdsl Limited | - |
Displaying 1 - 5 of 7
Calero Mdsl Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.